PR1921c : Prostate cancer with adjacent normal tissue and normal tissue array, including pathology grade, Gleason grade, Gleason score, TNM and clinical stage, PSA Marker result, 96 cases/192 cores, replaced by PR1921-L38 (core size 1.0 mm)
  • $594.00
  • Unstained
  • H&E
-+
Microarray Panel Prostate adenocarcinoma tissue microarray, containing 78 cases of adenocarcinoma, 2 cases of neuroendocrine carcinoma,8 adjacent normal prostate tissue and 8 normal prostate tissue, duplicate cores per case
Cores 192
TissueArray.Com Tissue Array PR1921c
Cases 96
Row number 12
Column number 16
Core Diameter (mm) 1
Thickness (µm) 5
Quality Control H&E and IHC confirmed
Tissue Array Type FFPE
Species Human
Notes 1. TMA slides were sectioned and stored at 4°C and may not be fresh cut, but still suitable for IHC. Please request fresh cut if experiment involves phospho-specific antibodies, RNA studies, FISH or ISH, etc. A minimum of 3 slides per TMA must be purchased to cover the cost of trimming for fresh sectioning. 2. Most TMA slides were not coated with an extra layer of paraffin (tissue cores can be easily seen on the glass). To prevent tissue detachment during antigen retrieval, unbaked slides must be baked for at least 30 to 120 minutes at 60°C. before putting into xylene for de-paraffinization. Baked slides were sent out baked for 2 hours.
In the following specsheet,“*” means invalid core; “-” means no applicable or negative in IHC markers.
Mouseover and click individual cores to view high resolution images.
Slide Label: TissueArray.Com Tissue Array
12345678910111213141516
A
B
C
D
E
F
G
H
I
J
K
L
Legend:

- AT, - Malignant tumor, - Malignant tumor (stage I), - Malignant tumor (stage II), - Malignant tumor (stage IIA), - Malignant tumor (stage IIB), - Malignant tumor (stage IIC), - Malignant tumor (stage III), - Malignant tumor (stage IIIB), - Malignant tumor (stage IV), - NAT, - Normal tissue

Specification Sheet (Sortable), tissue IDs are available in exported Excel files.
Pos.
No.
Age
Sex
Organ/Anatomic Site
Pathology diagnosis
TNM
Grade
Stage
Type
Gleason Score
Gleason Grade
PSA
Image
A1
1
66
M
Adenocarcinoma
T2N0M0
1
I
Malignant
2+3
1
+++
A2
2
66
M
Adenocarcinoma
T2N0M0
1
I
Malignant
2+3
1
+++
A3
3
75
M
Adenocarcinoma
T2N0M0
2
IIB
Malignant
4+3
3
+++
A4
4
75
M
Adenocarcinoma
T2N0M0
2
IIB
Malignant
4+3
3
+++
A5
5
60
M
Adenocarcinoma
-
2
-
Malignant
4+3
3
+++
A6
6
60
M
Adenocarcinoma
-
2
-
Malignant
4+3
3
+++
A7
7
67
M
Adenocarcinoma
T2N0M0
2
I
Malignant
3+3
1
+++
A8
8
67
M
Adenocarcinoma
T2N0M0
2
I
Malignant
3+3
1
+++
A9
9
71
M
Adenocarcinoma
T2N0M0
2
IIB
Malignant
4+4
4
+++
A10
10
71
M
Adenocarcinoma
T2N0M0
2
IIB
Malignant
4+4
4
+++
A11
11
60
M
Adenocarcinoma
T3N0M0
2
IIIB
Malignant
3+3
1
+++
A12
12
60
M
Adenocarcinoma
T3N0M0
2
IIIB
Malignant
3+3
1
+++
A13
13
82
M
Adenocarcinoma
-
2
-
Malignant
4+4
4
+++
A14
14
82
M
Adenocarcinoma
-
-
-
Malignant
4+4
4
+++
A15
15
64
M
Adenocarcinoma
T3N0M0
2
III
Malignant
4+3
3
+++
A16
16
64
M
Adenocarcinoma
T3N0M0
2
III
Malignant
4+3
3
+++
B1
17
64
M
Adenocarcinoma
T2N0M0
2
IIA
Malignant
3+4
2
+++
B2
18
64
M
Adenocarcinoma
T2N0M0
2
IIA
Malignant
3+4
2
+++
B3
19
81
M
Adenocarcinoma
T3N0M0
-
III
Malignant
4+4
4
+++
B4
20
81
M
Adenocarcinoma
T3N0M0
-
III
Malignant
4+4
4
+++
B5
21
64
M
Adenocarcinoma
T2N0M0
2
IIA
Malignant
3+4
2
+++
B6
22
64
M
Adenocarcinoma
T2N0M0
2
IIA
Malignant
3+4
2
+++
B7
23
82
M
Adenocarcinoma
T3N0M0
3
III
Malignant
5+4
5
+++
B8
24
82
M
Adenocarcinoma
T3N0M0
3
III
Malignant
5+4
5
+++
B9
25
73
M
Adenocarcinoma
T2N0M0
2
IIB
Malignant
4+4
4
+++
B10
26
73
M
Adenocarcinoma
T2N0M0
2
IIB
Malignant
4+4
4
+++
B11
27
74
M
Adenocarcinoma
T2N0M0
2
IIC
Malignant
3+3
1
+++
B12
28
74
M
Adenocarcinoma
T2N0M0
2
IIC
Malignant
3+3
1
+++
B13
29
69
M
Adenocarcinoma
T3N0M0
2
III
Malignant
3+4
2
+++
B14
30
69
M
Adenocarcinoma(prostate stromal)
T3N0M0
2
III
Malignant
3+4
2
*
B15
31
75
M
Adenocarcinoma
T2N0M0
1
I
Malignant
2+3
1
-
B16
32
75
M
Adenocarcinoma
T2N0M0
1
I
Malignant
2+3
1
+++
C1
33
70
M
Adenocarcinoma
T2N0M0
2
I
Malignant
3+3
1
+++
C2
34
70
M
Adenocarcinoma
T2N0M0
2
I
Malignant
3+3
1
+++
C3
35
75
M
Adenocarcinoma
T2N0M0
1
I
Malignant
3+2
1
+++
C4
36
75
M
Adenocarcinoma
T2N0M0
1
I
Malignant
3+2
1
+++
C5
37
65
M
Adenocarcinoma
T2N0M0
2
IIB
Malignant
3+5
4
+++
C6
38
65
M
Adenocarcinoma
T2N0M0
2
IIB
Malignant
3+5
4
+++
C7
39
73
M
Adenocarcinoma
T2N0M0
2
IIA
Malignant
3+4
2
+++
C8
40
73
M
Adenocarcinoma
T2N0M0
2
IIA
Malignant
3+4
2
+++
C9
41
68
M
Adenocarcinoma
T2N0M0
2
IIA
Malignant
3+4
2
+++
C10
42
68
M
Adenocarcinoma (sparse)
T2N0M0
2
IIA
Malignant
3+4
2
+++
C11
43
69
M
Adenocarcinoma
T2N0M0
2
IIA
Malignant
3+4
2
+++
C12
44
69
M
Adenocarcinoma
T2N0M0
2
IIA
Malignant
3+4
2
+++
C13
45
57
M
Adenocarcinoma
T2N0M0
2
IIA
Malignant
3+4
2
+++
C14
46
57
M
Adenocarcinoma
T2N0M0
2
IIA
Malignant
3+4
2
+++
C15
47
97
M
Adenocarcinoma
-
2
-
Malignant
4+4
4
+++
C16
48
97
M
Adenocarcinoma
-
2
-
Malignant
4+4
4
+++
D1
49
79
M
Adenocarcinoma
-
2
-
Malignant
3+3
1
+++
D2
50
79
M
Adenocarcinoma
-
2
-
Malignant
3+3
1
+++
D3
51
73
M
Adenocarcinoma
-
2
-
Malignant
3+3
1
+++
D4
52
73
M
Adenocarcinoma
-
2
-
Malignant
3+3
1
+++
D5
53
71
M
Adenocarcinoma
-
2
-
Malignant
3+4
2
+++
D6
54
71
M
Adenocarcinoma
-
2
-
Malignant
3+4
2
+++
D7
55
64
M
Adenocarcinoma
T2N0M0
2
IIB
Malignant
4+4
4
+++
D8
56
64
M
Adenocarcinoma
T2N0M0
2
IIB
Malignant
4+4
4
+++
D9
57
64
M
Adenocarcinoma
T2N0M0
2
IIA
Malignant
4+3
3
+++
D10
58
64
M
Adenocarcinoma
T2N0M0
2
IIA
Malignant
4+3
3
+++
D11
59
73
M
Adenocarcinoma
T3N0M0
2
III
Malignant
3+4
2
+++
D12
60
73
M
Adenocarcinoma
T3N0M0
2
III
Malignant
3+4
2
+++
D13
61
71
M
Adenocarcinoma
T2N0M0
2
II
Malignant
3+4
2
+++
D14
62
71
M
Adenocarcinoma
T2N0M0
2
II
Malignant
3+4
2
+++
D15
63
82
M
Adenocarcinoma
T2N0M0
2
IIB
Malignant
4+4
4
+++
D16
64
82
M
Adenocarcinoma
T2N0M0
2
IIB
Malignant
4+4
4
+++
E1
65
73
M
Adenocarcinoma
T2N0M0
2
IIA
Malignant
3+4
2
+++
E2
66
73
M
Adenocarcinoma
T2N0M0
2
IIA
Malignant
3+4
2
+++
E3
67
61
M
Adenocarcinoma
T2N0M0
2
IIB
Malignant
4+4
4
+++
E4
68
61
M
Adenocarcinoma
T2N0M0
2
IIB
Malignant
4+4
4
+++
E5
69
76
M
Adenocarcinoma
T2N0M0
2
IIA
Malignant
3+4
2
+++
E6
70
76
M
Adenocarcinoma
T2N0M0
2
IIA
Malignant
3+4
2
+++
E7
71
65
M
Adenocarcinoma
T2N0M0
2
IIA
Malignant
4+3
3
+++
E8
72
65
M
Adenocarcinoma
T2N0M0
2
IIA
Malignant
4+3
3
+++
E9
73
78
M
Adenocarcinoma
T4N0M0
3
IV
Malignant
5+5
5
+++
E10
74
78
M
Adenocarcinoma
T4N0M0
3
IV
Malignant
5+5
5
+++
E11
75
64
M
Adenocarcinoma
T2N0M0
2
IIB
Malignant
4+4
4
+++
E12
76
64
M
Adenocarcinoma
T2N0M0
2
IIB
Malignant
4+4
4
+++
E13
77
63
M
Adenocarcinoma
T2N0M0
2
IIB
Malignant
4+4
4
+++
E14
78
63
M
Adenocarcinoma
T2N0M0
2
IIB
Malignant
4+4
4
+++
E15
79
62
M
Adenocarcinoma
T2N0M0
2
IIB
Malignant
4+4
4
+++
E16
80
62
M
Adenocarcinoma
T2N0M0
2
IIB
Malignant
4+4
4
+++
F1
81
70
M
Adenocarcinoma
T3N0M0
2
III
Malignant
4+4
4
+++
F2
82
70
M
Adenocarcinoma
T3N0M0
2
III
Malignant
4+4
4
+++
F3
83
20
M
Adenocarcinoma
T3N0M0
2
III
Malignant
4+4
4
+++
F4
84
20
M
Adenocarcinoma
T3N0M0
2
III
Malignant
4+4
4
+++
F5
85
62
M
Adenocarcinoma
T3N0M0
2
III
Malignant
4+4
4
+++
F6
86
62
M
Adenocarcinoma
T3N0M0
2
III
Malignant
4+4
4
+++
F7
87
73
M
Adenocarcinoma
T3N0M0
2
III
Malignant
4+4
4
+++
F8
88
73
M
Adenocarcinoma
T3N0M0
2
III
Malignant
4+4
4
+++
F9
89
80
M
Adenocarcinoma
T3N0M0
2
III
Malignant
4+4
4
+++
F10
90
80
M
Adenocarcinoma
T3N0M0
2
III
Malignant
4+4
4
+++
F11
91
61
M
Adenocarcinoma
-
2
-
Malignant
4+4
4
++
F12
92
61
M
Adenocarcinoma
-
2
-
Malignant
4+4
4
++
F13
93
68
M
Adenocarcinoma
-
-
-
Malignant
4+4
4
++
F14
94
68
M
Adenocarcinoma
-
-
-
Malignant
4+4
4
++
F15
95
72
M
Neuroendocrine carcinoma?
T2N0M0
3
IIB
Malignant
-
F16
96
72
M
Neuroendocrine carcinoma?
T2N0M0
3
IIB
Malignant
-
G1
97
69
M
Adenocarcinoma
-
2
-
Malignant
4+4
4
+++
G2
98
69
M
Adenocarcinoma
-
2
-
Malignant
4+4
4
+++
G3
99
65
M
Adenocarcinoma
-
2
-
Malignant
4+4
4
+++
G4
100
65
M
Adenocarcinoma
-
2
-
Malignant
4+4
4
+++
G5
101
72
M
Adenocarcinoma
T3N0M0
3
III
Malignant
5+5
5
+++
G6
102
72
M
Adenocarcinoma
T3N0M0
3
III
Malignant
5+5
5
+++
G7
103
62
M
Adenocarcinoma
T2N0M0
3
IIB
Malignant
5+5
5
+++
G8
104
62
M
Adenocarcinoma
T2N0M0
3
IIB
Malignant
5+5
5
+++
G9
105
78
M
Adenocarcinoma
T3N0M0
3
III
Malignant
5+5
5
+++
G10
106
78
M
Adenocarcinoma
T3N0M0
3
III
Malignant
5+5
5
+++
G11
107
65
M
Adenocarcinoma
-
2
-
Malignant
4+4
4
+++
G12
108
65
M
Adenocarcinoma
-
2
-
Malignant
4+4
4
+++
G13
109
60
M
Adenocarcinoma
T2N0M0
3
IIB
Malignant
5+5
5
+++
G14
110
60
M
Adenocarcinoma
T2N0M0
3
IIB
Malignant
5+5
5
+++
G15
111
73
M
Adenocarcinoma
T3N0M0
2
III
Malignant
3+4
2
+++
G16
112
73
M
Adenocarcinoma
T3N0M0
2
III
Malignant
3+4
2
+++
H1
113
72
M
Adenocarcinoma
T3N0M0
3
III
Malignant
4+5
5
+++
H2
114
72
M
Adenocarcinoma
T3N0M0
3
III
Malignant
4+5
5
+++
H3
115
82
M
Adenocarcinoma
T2N0M0
3
IIB
Malignant
5+5
5
+++
H4
116
82
M
Adenocarcinoma
T2N0M0
3
IIB
Malignant
5+5
5
+++
H5
117
62
M
Adenocarcinoma
T2N0M0
3
IIB
Malignant
5+5
5
+++
H6
118
62
M
Adenocarcinoma
T2N0M0
3
IIB
Malignant
5+5
5
+++
H7
119
77
M
Adenocarcinoma
T2N0M0
3
IIB
Malignant
4+5
5
+++
H8
120
77
M
Adenocarcinoma
T2N0M0
3
IIB
Malignant
4+5
5
+++
H9
121
87
M
Adenocarcinoma
T2N0M0
3
IIB
Malignant
5+5
5
+++
H10
122
87
M
Adenocarcinoma
T2N0M0
3
IIB
Malignant
5+5
5
+++
H11
123
69
M
Neuroendocrine carcinoma?
T2N0M0
3
IIB
Malignant
-
H12
124
69
M
Neuroendocrine carcinoma?
T2N0M0
3
IIB
Malignant
-
H13
125
56
M
Adenocarcinoma
T3N0M0
3
III
Malignant
5+5
5
++
H14
126
56
M
Adenocarcinoma
T3N0M0
3
III
Malignant
5+5
5
++
H15
127
68
M
Adenocarcinoma (sparse)
T2N0M0
3
IIB
Malignant
4+5
5
+++
H16
128
68
M
Adenocarcinoma
T2N0M0
3
IIB
Malignant
4+5
5
+++
I1
129
76
M
Adenocarcinoma (sparse)
T3N0M0
3
III
Malignant
5+5
5
+++
I2
130
76
M
Adenocarcinoma
T3N0M0
3
III
Malignant
5+5
5
+++
I3
131
60
M
Adenocarcinoma
T2N0M0
2
IIC
Malignant
3+4
2
+++
I4
132
60
M
Adenocarcinoma
T2N0M0
2
IIC
Malignant
3+4
2
+++
I5
133
76
M
Adenocarcinoma (sparse)
T2N0M0
3
IIB
Malignant
5+5
5
+++
I6
134
76
M
Adenocarcinoma
T2N0M0
3
IIB
Malignant
5+5
5
+++
I7
135
73
M
Adenocarcinoma
T4N0M0
3
IV
Malignant
5+4
5
+++
I8
136
73
M
Adenocarcinoma
T4N0M0
3
IV
Malignant
5+4
5
+++
I9
137
66
M
Adenocarcinoma
T3N0M0
3
III
Malignant
5+5
5
+++
I10
138
66
M
Adenocarcinoma
T3N0M0
3
III
Malignant
5+5
5
+++
I11
139
69
M
Adenocarcinoma
-
2
-
Malignant
4+4
4
++
I12
140
69
M
Adenocarcinoma
-
2
-
Malignant
4+4
4
++
I13
141
77
M
Adenocarcinoma
-
2
-
Malignant
4+4
4
+++
I14
142
77
M
Adenocarcinoma
-
2
-
Malignant
4+4
4
+++
I15
143
79
M
Adenocarcinoma
-
3
-
Malignant
5+5
5
+
I16
144
79
M
Adenocarcinoma
-
3
-
Malignant
5+5
5
++
J1
145
78
M
Adenocarcinoma
-
3
-
Malignant
5+4
5
++
J2
146
78
M
Adenocarcinoma
-
3
-
Malignant
5+4
5
++
J3
147
69
M
Adenocarcinoma
-
3
-
Malignant
5+4
5
++
J4
148
69
M
Adenocarcinoma
-
3
-
Malignant
5+4
5
++
J5
149
70
M
Adenocarcinoma
-
3
-
Malignant
5+4
5
++
J6
150
70
M
Adenocarcinoma
-
3
-
Malignant
5+4
5
*
J7
151
65
M
Adenocarcinoma
-
3
-
Malignant
4+5
5
+++
J8
152
65
M
Adenocarcinoma
-
3
-
Malignant
4+5
5
+++
J9
153
69
M
Adenocarcinoma
-
3
-
Malignant
5+5
5
+
J10
154
69
M
Adenocarcinoma
-
3
-
Malignant
5+5
5
+
J11
155
68
M
Adenocarcinoma
-
3
-
Malignant
5+5
5
+
J12
156
68
M
Adenocarcinoma
-
3
-
Malignant
5+5
5
+
J13
157
68
M
Adenocarcinoma
-
3
-
Malignant
5+5
5
++
J14
158
68
M
Adenocarcinoma
-
3
-
Malignant
5+5
5
++
J15
159
72
M
Adenocarcinoma
T3N0M0
3
III
Malignant
5+5
5
+++
J16
160
72
M
Adenocarcinoma
T3N0M0
3
III
Malignant
5+5
5
+++
K1
161
21
M
Adjacent normal prostate tissue
-
-
-
NAT
-
-
+++
K2
162
21
M
Adjacent normal prostate tissue
-
-
-
NAT
-
-
+++
K3
163
35
M
Adjacent normal prostate tissue
-
-
-
NAT
-
-
+++
K4
164
35
M
Adjacent normal prostate tissue
-
-
-
NAT
-
-
+++
K5
165
56
M
Adjacent normal prostate tissue
-
-
-
NAT
-
-
+++
K6
166
56
M
Adjacent normal prostate tissue
-
-
-
NAT
-
-
+++
K7
167
62
M
Adjacent normal prostate tissue
-
-
-
NAT
-
-
+++
K8
168
62
M
Adjacent normal prostate tissue
-
-
-
NAT
-
-
+++
K9
169
57
M
Cancer adjacent prostate tissue
-
-
-
AT
-
-
+++
K10
170
57
M
Cancer adjacent prostate tissue
-
-
-
AT
-
-
+++
K11
171
60
M
Adjacent normal prostate tissue
-
-
-
NAT
-
-
+++
K12
172
60
M
Adjacent normal prostate tissue
-
-
-
NAT
-
-
+++
K13
173
68
M
Adjacent normal prostate tissue
-
-
-
NAT
-
-
+++
K14
174
68
M
Adjacent normal prostate tissue
-
-
-
NAT
-
-
+
K15
175
74
M
Adjacent normal prostate tissue
-
-
-
NAT
-
-
+++
K16
176
74
M
Adjacent normal prostate tissue(prostate stromal)
-
-
-
NAT
-
-
*
L1
177
74
M
Prostate tissue
-
-
Normal
+++
L2
178
74
M
Prostate tissue
-
-
Normal
+++
L3
179
37
M
Prostate tissue
-
-
-
Normal
-
-
+++
L4
180
37
M
Prostate tissue
-
-
-
Normal
-
-
+++
L5
181
42
M
Prostate tissue
-
-
-
Normal
-
-
+++
L6
182
42
M
Prostate tissue
-
-
-
Normal
-
-
+++
L7
183
29
M
Prostate tissue
-
-
-
Normal
-
-
+++
L8
184
29
M
Prostate tissue
-
-
-
Normal
-
-
+++
L9
185
34
M
Prostate tissue
-
-
-
Normal
-
-
+++
L10
186
34
M
Prostate tissue
-
-
-
Normal
-
-
+++
L11
187
31
M
Prostate tissue
-
-
-
Normal
-
-
+++
L12
188
31
M
Prostate tissue
-
-
-
Normal
-
-
+++
L13
189
22
M
Prostate tissue
-
-
-
Normal
-
-
+++
L14
190
22
M
Prostate tissue
-
-
-
Normal
-
-
+++
L15
191
28
M
Prostate tissue
-
-
-
Normal
-
-
+++
L16
192
28
M
Prostate tissue
-
-
-
Normal
-
-
+++
Find overlapping cases with this tissue array:
 

Write a review

Please login or register to review
 
  • Product Code: PR1921c
  • Availability: In Stock

Tags: Stage (TNM), Normal tissue array, Single core per case